Encompass Health Co. (NYSE:EHC) Receives Average Rating of “Buy” from Analysts

Shares of Encompass Health Co. (NYSE:EHCGet Free Report) have earned a consensus recommendation of “Buy” from the eight brokerages that are currently covering the company, MarketBeat reports. Seven equities research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $93.29.

A number of brokerages have recently issued reports on EHC. Mizuho raised their target price on shares of Encompass Health from $93.00 to $95.00 and gave the stock a “buy” rating in a research report on Thursday, April 25th. Royal Bank of Canada lifted their target price on shares of Encompass Health from $83.00 to $95.00 and gave the company an “outperform” rating in a report on Wednesday, May 22nd. Raymond James restated a “strong-buy” rating and issued a $95.00 price objective (up previously from $85.00) on shares of Encompass Health in a research report on Friday, April 26th. Barclays boosted their target price on Encompass Health from $101.00 to $108.00 and gave the stock an “overweight” rating in a research report on Thursday, April 25th. Finally, Stephens reissued an “overweight” rating and issued a $94.00 price target on shares of Encompass Health in a report on Wednesday, June 5th.

Read Our Latest Stock Analysis on Encompass Health

Insider Buying and Selling at Encompass Health

In other Encompass Health news, insider Elissa Joy Charbonneau sold 10,000 shares of the business’s stock in a transaction dated Friday, May 24th. The shares were sold at an average price of $85.02, for a total value of $850,200.00. Following the transaction, the insider now directly owns 18,594 shares in the company, valued at $1,580,861.88. The transaction was disclosed in a document filed with the SEC, which is available through this link. In other Encompass Health news, EVP John Patrick Darby sold 14,543 shares of the business’s stock in a transaction dated Monday, May 6th. The shares were sold at an average price of $83.94, for a total value of $1,220,739.42. Following the completion of the transaction, the executive vice president now directly owns 84,773 shares of the company’s stock, valued at $7,115,845.62. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Elissa Joy Charbonneau sold 10,000 shares of the company’s stock in a transaction that occurred on Friday, May 24th. The stock was sold at an average price of $85.02, for a total transaction of $850,200.00. Following the transaction, the insider now owns 18,594 shares in the company, valued at $1,580,861.88. The disclosure for this sale can be found here. Insiders have sold 69,519 shares of company stock valued at $5,816,091 in the last 90 days. 2.10% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Encompass Health

Several hedge funds have recently added to or reduced their stakes in EHC. Legacy Wealth Asset Management LLC increased its stake in shares of Encompass Health by 1.5% in the 1st quarter. Legacy Wealth Asset Management LLC now owns 8,619 shares of the company’s stock valued at $712,000 after acquiring an additional 130 shares during the last quarter. Smith Group Asset Management LLC increased its position in Encompass Health by 1.2% during the 1st quarter. Smith Group Asset Management LLC now owns 12,070 shares of the company’s stock worth $997,000 after buying an additional 140 shares during the period. Benjamin Edwards Inc. raised its stake in Encompass Health by 3.8% in the 4th quarter. Benjamin Edwards Inc. now owns 3,885 shares of the company’s stock worth $259,000 after purchasing an additional 142 shares in the last quarter. Horrell Capital Management Inc. grew its position in Encompass Health by 0.5% during the first quarter. Horrell Capital Management Inc. now owns 29,371 shares of the company’s stock worth $2,425,000 after buying an additional 147 shares in the last quarter. Finally, GAMMA Investing LLC raised its stake in Encompass Health by 31.9% in the first quarter. GAMMA Investing LLC now owns 616 shares of the company’s stock valued at $51,000 after purchasing an additional 149 shares in the last quarter. Institutional investors own 97.25% of the company’s stock.

Encompass Health Price Performance

Shares of NYSE EHC opened at $83.99 on Tuesday. The firm has a 50-day simple moving average of $85.13 and a 200-day simple moving average of $78.39. The company has a quick ratio of 1.37, a current ratio of 1.37 and a debt-to-equity ratio of 1.14. The stock has a market capitalization of $8.46 billion, a price-to-earnings ratio of 22.70, a price-to-earnings-growth ratio of 1.33 and a beta of 0.89. Encompass Health has a 52 week low of $57.55 and a 52 week high of $87.94.

Encompass Health (NYSE:EHCGet Free Report) last announced its earnings results on Wednesday, April 24th. The company reported $1.12 earnings per share for the quarter, topping the consensus estimate of $0.93 by $0.19. Encompass Health had a net margin of 7.60% and a return on equity of 18.01%. The company had revenue of $1.32 billion during the quarter, compared to analyst estimates of $1.27 billion. During the same quarter last year, the firm posted $0.88 earnings per share. Encompass Health’s revenue was up 13.4% compared to the same quarter last year. On average, equities analysts predict that Encompass Health will post 4.1 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, July 15th. Stockholders of record on Monday, July 1st will be paid a dividend of $0.15 per share. The ex-dividend date of this dividend is Monday, July 1st. This represents a $0.60 annualized dividend and a dividend yield of 0.71%. Encompass Health’s dividend payout ratio (DPR) is presently 16.22%.

Encompass Health Company Profile

(Get Free Report

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

See Also

Analyst Recommendations for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.